Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system - PubMed (original) (raw)

Review

Inflammatory mechanisms associated with brain damage induced by kainic acid with special reference to the interleukin-1 system

M Oprica et al. J Cell Mol Med. 2003 Apr-Jun.

Abstract

The evidence of inflammatory processes in the clinical manifestations and neuropathological sequelae of epilepsy have accumulated in the last decade. Administration of kainic acid, an analogue of the excitatory amino acid glutamate, induces a characteristic behavioural syndrome and a reproducible pattern of neurodegeneration in several brain areas, closely resembling human temporal lobe epilepsy. Results from studies using the kainic acid model indicate that manipulation of pro- and anti-inflammatory cytokines can modify the outcome with regard to the behavioural syndrome as well as the neuropathological consequences. Interleukin-1 is one of the most important cytokines and has several actions in the brain that are critical for the host defense against injury and infection, and it is involved in the initiation of early stages of inflammation. It is believed that interleukin-1 plays a pivotal role in the neuroinflammation associated with certain forms of neurodegeneration, including cerebral ischemia, trauma and excitotoxic brain injury. In this review, we have summarized the experimental data available with regard to the involvement of the interleukin-1 system in kainic acid-induced changes in the brain and emphasized the modulatory role of interleukin-1beta in this model of epilepsy

PubMed Disclaimer

Similar articles

• Increased expression of mRNA encoding interleukin-1beta and caspase-1, and the secreted isoform of interleukin-1 receptor antagonist in the rat brain following systemic kainic acid administration.
  Eriksson C, Tehranian R, Iverfeldt K, Winblad B, Schultzberg M. Eriksson C, et al. J Neurosci Res. 2000 Apr 15;60(2):266-79. doi: 10.1002/(SICI)1097-4547(20000415)60:2<266::AID-JNR16>3.0.CO;2-P. J Neurosci Res. 2000. PMID: 10740232
• The influence of kainic acid on core temperature and cytokine levels in the brain.
  Oprica M, Spulber SD, Aronsson AF, Post C, Winblad B, Schultzberg M. Oprica M, et al. Cytokine. 2006 Jul;35(1-2):77-87. doi: 10.1016/j.cyto.2006.07.011. Epub 2006 Sep 6. Cytokine. 2006. PMID: 16950633
• [Kainic acid and neurobiology].
  Riljak V, Jandová K, Langmeier M. Riljak V, et al. Cesk Fysiol. 2006;55(3):115-22. Cesk Fysiol. 2006. PMID: 17685017 Review. Czech.
• The kainic acid model of temporal lobe epilepsy.
  Lévesque M, Avoli M. Lévesque M, et al. Neurosci Biobehav Rev. 2013 Dec;37(10 Pt 2):2887-99. doi: 10.1016/j.neubiorev.2013.10.011. Epub 2013 Oct 30. Neurosci Biobehav Rev. 2013. PMID: 24184743 Free PMC article. Review.

Cited by

• From single-SNP to wide-locus: genome-wide association studies identifying functionally related genes and intragenic regions in small sample studies.
  Wittkowski KM, Sonakya V, Song T, Seybold MP, Keddache M, Durner M. Wittkowski KM, et al. Pharmacogenomics. 2013 Mar;14(4):391-401. doi: 10.2217/pgs.13.28. Pharmacogenomics. 2013. PMID: 23438886 Free PMC article.
• Pretreatment with Methylene Blue Protects Against Acute Seizure and Oxidative Stress in a Kainic Acid-Induced Status Epilepticus Model.
  Wang YF, Luo Y, Hou GL, He RJ, Zhang HY, Yi YL, Zhang Y, Cui ZQ. Wang YF, et al. Med Sci Monit. 2021 Oct 10;27:e933469. doi: 10.12659/MSM.933469. Med Sci Monit. 2021. PMID: 34628461 Free PMC article.
• New roles for interleukin-1 Beta in the mechanisms of epilepsy.
  Vezzani A, Baram TZ. Vezzani A, et al. Epilepsy Curr. 2007 Mar-Apr;7(2):45-50. doi: 10.1111/j.1535-7511.2007.00165.x. Epilepsy Curr. 2007. PMID: 17505552 Free PMC article.
• The neuroprotective effect of a specific P2X₇ receptor antagonist derives from its ability to inhibit assembly of the NLRP3 inflammasome in glial cells.
  Murphy N, Cowley TR, Richardson JC, Virley D, Upton N, Walter D, Lynch MA. Murphy N, et al. Brain Pathol. 2012 May;22(3):295-306. doi: 10.1111/j.1750-3639.2011.00531.x. Epub 2011 Oct 27. Brain Pathol. 2012. PMID: 21933296 Free PMC article.
• The role of inflammation in epileptogenesis.
  Vezzani A, Friedman A, Dingledine RJ. Vezzani A, et al. Neuropharmacology. 2013 Jun;69:16-24. doi: 10.1016/j.neuropharm.2012.04.004. Epub 2012 Apr 13. Neuropharmacology. 2013. PMID: 22521336 Free PMC article. Review.

References

1. 1. Schneider H., Pitossi F., Balschun D., Wagner A., del Rey A., Besedovsky H.O., A neuromodulatory role of interleukin‐1beta in the hippocampus, Proc. Natl. Acad. Sci., 95: 7778–7783, 1998. - PMC - PubMed
2. 1. Opp M.R., Krueger J.M., Interleukin 1‐receptor antagonist blocks interleukin 1‐induced sleep and fever, Am. J. Physiol., 260: R453–457, 1991. - PubMed
3. 1. Berkenbosch F., van Oers J., del Rey A., Tilders F., Besedovsky H., Corticotropin‐releasing factor‐producing neurons in the rat activated by interleukin‐1, Science, 238: 524–526, 1987. - PubMed
4. 1. Tehranian R., Andell‐Jonsson S., Beni S.M., Yatsiv I., Shohami E., Bartfai T., Lundkvist J., Iverfeldt K., Improved recovery and delayed cytokine induction after closed head injury in mice with central overexpression of the secreted isoform of the interleukin‐1 receptor antagonist, J. Neurotrauma, 19: 939–951, 2002. - PubMed
5. 1. Loddick S.A., Wong M.L., Bongiorno P.B., Gold P.W., Licinio J., Rothwell NJ., Endogenous interleukin‐1 receptor antagonist is neuroprotective, Biochem. Biophys. Res. Commun., 234: 211–215, 1997. - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Europe PubMed Central
  • Ovid Technologies, Inc.
  • PubMed Central
  • Wiley